Signal transduction by the CEACAM1 tumor suppressor. Phosphorylation of serine 503 is required for growth-inhibitory

V T Estrera1, D T Chen, W Luo

  • 1Department of Molecular Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

Insights

Phosphorylation of serine 503 in CEACAM1 is crucial for its tumor-suppressive activity. This finding is vital for understanding CEACAM1

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • CEACAM1 is a cell-cell adhesion molecule with demonstrated tumor-suppressive roles in prostate, breast, and colon cancers.
  • CEACAM1's extracellular domain mediates adhesion, while its cytoplasmic domain is key for growth inhibition.
  • The precise signaling pathways underlying CEACAM1's tumor suppression remain largely unknown.

Purpose of the Study:

  • To investigate the role of serine 503 phosphorylation in the growth-inhibitory signaling pathway of CEACAM1.
  • To determine the significance of tyrosine 488 and serine 503 phosphorylation for CEACAM1's tumor-suppressive function.

Main Methods:

  • Analysis of in vivo phosphorylation of full-length CEACAM1 at tyrosine and serine residues.
  • Site-directed mutagenesis of tyrosine 488 to phenylalanine and serine 503 to alanine or aspartic acid.
  • Assessment of the impact of these mutations on CEACAM1's growth-inhibitory activity in DU145 prostate cancer cells.

Main Results:

  • CEACAM1 is phosphorylated on both tyrosine and serine residues in vivo.
  • Mutation of tyrosine 488 did not affect CEACAM1's tumor-suppressive activity.
  • Mutation of serine 503 to alanine abolished growth inhibition, while mutation to aspartic acid mimicked wild-type activity.

Conclusions:

  • Phosphorylation at serine 503 is essential for the in vivo tumor-suppressive function of CEACAM1.
  • Tyrosine 488 phosphorylation is not critical for CEACAM1's growth-inhibitory role.
  • These findings elucidate a key mechanism in CEACAM1-mediated cancer growth suppression.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...